Exhaled leukotriene B4 and nitric oxide in cystic fibrosis  by Bloemen, K. et al.
6. Immunology S57
225 Exhaled leukotriene B4 and nitric oxide in cystic ﬁbrosis
K. Bloemen1, V. Nelen2, G. Schoeters1, K. Desager3. 1VITO N.V., Mol, Belgium;
2PIH, Antwerp, Belgium; 3UZA, Antwerp, Belgium
Cystic ﬁbrosis (CF) is the most commonly inherited lethal pulmonary disorder in
Caucasians. Progressive lung disease, characterized by a self-perpetuating cycle of
airway obstruction, chronic bacterial infection and inﬂammation, is the main cause
of morbidity and mortality in CF patients.
The aim of this study is to search for inﬂammatory markers for CF. Exhaled breath
condensate (EBC) is used more and more in the search for noninvasive biomarkers
for airway diseases. Samples were collected from 32 CF patients, of which 9 were
chronically colonized with Pseudomonas aeruginosa and 21 healthy controls (age
6−23 years). EBC was collected by tidal breathing during 15 minutes in a RTube
(Respiratory Research). NO was measured with a NIOX Mino (Aerocrine). EBC
pH was measured without deaeration, exactly 5 minutes after sample collection.
Exhaled LTB4, measurable in 73% of the samples (EIA, Cayman), was signiﬁcantly
higher in CF patients compared to healthy controls (median: 5.71 vs 3.59 pg/ml;
Mann-Whitney U test: p = 0.0029). Values were especially elevated in CF patients
with P. aeruginosa (10.05 pg/ml), but not signiﬁcantly higher than in other CF
patients. Gender, body weight, height or age didn’t have an inﬂuence on exhaled
LTB4. EBC pH was lower in the CF patients than in the control group, but
the difference was not signiﬁcant (median: 5.37 vs 5.70). No correlation was
observed between LTB4 and EBC pH. Exhaled NO was signiﬁcantly lower in CF
patients compared to healthy controls (median: 8 vs 10 ppb; p = 0.010). A small but
signiﬁcant negative correlation between LTB4 and logNO was observed (p = 0.049).
These data suggest that exhaled LTB4, which has potent chemotactic activity for
neutrophils, could be used to monitor airway inﬂammation in CF patients.
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Neutrophilic inﬂammation is characteristic for CF lung disease. Neutrophil elastase
(NE) is a marker of neutrophilic inﬂammation.
We examined NE in exhaled breath condensate (EBC) in 53 CF adults (29 M)
aged 25.7±4.7 (mean±SD) years with FEV1 55.5±23.1% pred. and in 26 healthy
controls (8M) aged 28.4±4.8 years by using ECoScreen condenser and ELISA
method (lower detection limit given by manufacturer was 3 ng/ml).
NE was detectable in EBC in 34.0% of CF patients and 34.6% of healthy controls.
Detection didn’t depend on sex (p = 0.636), age (p = 0.134), FEV1 (p = 0.669) and
bacterial colonization of airways (p = 0.67) in CF patients. NE tended to be higher
in CF patients, 3.9 (1.7–9.0) vs. 1.8 (1.0–3.4) ng/ml (mean and 95%CI), p = 0.204.
NE correlated neither with EBC pH (p = 0.726) nor with EBC concentration of
leukotriene B4 (p = 0.88). NE also didn’t correlate with FEV1 (p = 0.805).
Based on these results, examination of NE in EBC by this means isn’t useful for
evaluation of neutrophilic inﬂammation in CF airways, probably due to detection
limit. More sensitive methods are needed for future research in this ﬁeld and
suitability of ECoScreen condenser should be evaluated for this biomarker.
Supported by: IGA MZCR NR/8304−3.
